Twenty-one of America's Top Early-Career Scientists Named 2010 Pew Scholars in the Biomedical Sciences

Navigate to:

Twenty-one of America's Top Early-Career Scientists Named 2010 Pew Scholars in the Biomedical Sciences

PHILADELPHIA, PA - The Pew Charitable Trusts today named 21 talented scientists as Pew Scholars in the Biomedical Sciences. The program enables scientists to take calculated risks, expand their research and explore unanticipated leads. Scholars receive $240,000 over four years and gain inclusion into a select community of scientists that includes three Nobel Prize winners, three MacArthur Fellows and two recipients of the Albert Lasker Medical Research Award.

Celebrating its 25th anniversary, the program has invested more than $125 million to fund close to 500 scholars. Many of the nation's best early-career scientists—working in all areas of physical and life sciences related to biomedical research—apply to the rigorously competitive program. Applicants are nominated by one of 155 invited institutions and demonstrate excellence and innovation in their research.

“Twenty-five years ago, The Pew Charitable Trusts identified a tremendous opportunity to impact the world of science by supporting the most promising young investigators and encouraging them to pursue their best ideas without restrictions,” said Rebecca W. Rimel, president and CEO of The Pew Charitable Trusts. “Motivating scientists at this point in their careers is essential to advancing discovery and innovation, and Pew is honored to continue its commitment to this cadre of high-quality researchers.”

This year, through the generosity of Kathryn W. Davis, Pew is able to expand its Biomedical Scholars program to include an additional twenty outstanding assistant professor level researchers to be named Pew Scholars over the next four years.  Aligned with Mrs. Davis' interest in identifying the causes of and discovering a cure for glaucoma, the additional Pew Scholars, supported by this $5.6 million initiative, will have tremendous potential for uncovering vital clues to many debilitating ocular diseases. 

“Being named a Pew Biomedical Scholar early in my career gave me the confidence and resources I needed to pursue new research areas,” said Nobel Prize winner and 1990 Pew Biomedical Scholar, Dr. Carol Greider. “In addition, the Pew Scholars program brings together a cohort of young investigators to interact with each other and learn something new along the way.”

Work by 2010 Pew Scholars in the Biomedical Sciences includes research related to cancer, Alzheimer's, Autism, Glaucoma, Parkinson's disease and birth defects. The 2010 Pew Scholars in the Biomedical Sciences are:

Scholar Institution And Field
Gregory C. Amberg, Pharm.D., Ph.D. Colorado State University Physiology and Biophysics
Fernando D. Camargo, Ph.D. Children's Hospital Boston Developmental and Cancer Biology
Erin E. Carlson, Ph.D. Indiana University Natural Product Drug Discovery
Mathew J. Evans, Ph.D. Mount Sinai School of Medicine Virology, Hepatitis C virus
Winrich A. Freiwald, Ph.D. The Rockefeller University Neuroscience
Alexander Gimelbrant, Ph.D. Dana-Farber Cancer Institute Gene Regulation and Epigenetics
David Guertin, Ph.D. University of Massachusetts Medical School Stem Cells and Regenerative Medicine
Valerie Horsley, Ph.D. Yale University Developmental and Stem Cell Biology
Sun Hur, Ph.D. Harvard Medical School Structural Biology and Immunology
Raquel Lieberman, Ph.D. Georgia Institute of Technology Structure/Function of Membrane Proteins
Andrej Luptak, Ph.D. University of California, Irvine RNA Molecular Biology
Craig T. Miller, Ph.D. University of California, Berkeley Developmental Biology and Evolution
Heather W. Pinkett, Ph.D. Northwestern University Structure/Function of Membrane Proteins
Rajat Rohatgi, M.D., Ph.D. Stanford University School of Medicine Signal Transduction in Development and Disease
Jeroen Saeij, Ph.D. Massachusetts Institute of Technology Genetics of Host-Pathogen Interactions
Susan Schwab, Ph.D. New York University School of Medicine Immunology
Jingshi Shen, Ph.D. University of Colorado, Boulder Cell Biology, Membrane Transport
Peter Tessier, Ph.D. Rensselaer Polytechnic Institute Biochemistry and Structural Biology
Changchun Xiao, Ph.D. The Scripps Research Institute Immunology
Bing Ye, Ph.D. University of Michigan Neuroscience
Zhaolan Zhou, Ph.D. University of Pennsylvania Neuroscience
 
“This immensely talented and diverse new class of Pew Scholars will undoubtedly have a major impact on biomedical research through their contributions as part of the Pew community and on science as a whole. Their discoveries over time will lead to new medical breakthroughs and improve human health,” said Craig C. Mello, Ph.D., a 1995 Pew Scholar and a 2006 Nobel laureate in physiology or medicine, and the chair of the national advisory committee for the program.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.